Stay updated with breaking news from Ikarian capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Wedbush restated their outperform rating on shares of Aerovate Therapeutics (NASDAQ:AVTE – Free Report) in a research report report published on Wednesday, Benzinga reports. The brokerage currently has a $41.00 price target on the stock. AVTE has been the subject of a number of other reports. Wells Fargo & Company reissued an overweight rating and […] ....
Protara Therapeutics, Inc. (NASDAQ:TARA – Get Free Report) major shareholder Opaleye Management Inc. sold 33,000 shares of the stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $3.06, for a total transaction of $100,980.00. Following the sale, the insider now directly owns 124,250 shares of the company’s […] ....
HC Wainwright restated their buy rating on shares of BiomX (NYSEMKT:PHGE – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. The brokerage currently has a $2.00 target price on the stock. HC Wainwright also issued estimates for BiomX’s Q2 2024 earnings at ($0.12) EPS, Q3 2024 earnings at ($0.13) […] ....
Research analysts at SVB Leerink initiated coverage on shares of Q32 Bio (NASDAQ:QTTB – Get Free Report) in a note issued to investors on Tuesday, Briefing.com reports. The brokerage set an “outperform” rating and a $54.00 price target on the stock. SVB Leerink’s price objective would indicate a potential upside of 78.81% from the company’s […] ....
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report)’s share price hit a new 52-week high on Tuesday . The stock traded as high as $50.30 and last traded at $50.00, with a volume of 58166 shares trading hands. The stock had previously closed at $48.55. Analyst Upgrades and Downgrades Several equities analysts recently weighed […] ....